Newsletter – July 2022 – Biotech Fund

At the closing bell on the last trading day of the Financial Year, the ASX Biotech Sector was down approximately 40% for the full Financial Year. Read more.

Get in Touch

  • This field is for validation purposes and should be left unchanged.